Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli

The genes for Nipah virus (NiV) proteins were amplified from viral RNA, cloned into the plasmid pTriEx-3 Hygro, expressed, and purified using immobilized metal affinity chromatography. The recombinant N, F, and G NiV proteins (rNiV-N, rNiV-F, and rNiV-G), were successfully expressed in Escherichia c...

Full description

Bibliographic Details
Main Authors: Tiong, Vunjia, Lam, Chui Wan, Phoon, Wai Hong, AbuBakar, Sazaly, Chang, Li Yen
Format: Article
Published: Institute of Infectious Diseases 2017
Subjects:
_version_ 1825721957669142528
author Tiong, Vunjia
Lam, Chui Wan
Phoon, Wai Hong
AbuBakar, Sazaly
Chang, Li Yen
author_facet Tiong, Vunjia
Lam, Chui Wan
Phoon, Wai Hong
AbuBakar, Sazaly
Chang, Li Yen
author_sort Tiong, Vunjia
collection UM
description The genes for Nipah virus (NiV) proteins were amplified from viral RNA, cloned into the plasmid pTriEx-3 Hygro, expressed, and purified using immobilized metal affinity chromatography. The recombinant N, F, and G NiV proteins (rNiV-N, rNiV-F, and rNiV-G), were successfully expressed in Escherichia coli and purified with a yield of 4, 16, and 4 mg/L, respectively. All 3 recombinant viral proteins reacted with all 19 samples of NiV-positive human sera. The rNiV-N and rNiV-G proteins were the most immunogenic. The recombinant viral proteins did not react with any of the 12 NiV-negative sera. However, serum from a patient with a late-onset relapsing NiV infection complication was found to be primarily reactive to rNiV-G only. Additionally, there is a distinctive variation in the profile of antigen-reactive bands between the sample from a case of relapsing NiV encephalitis and that of acute NiV infection. The overall findings of this study suggest that the recombinant viral proteins have the potential to be developed further for use in the detection of NiV infection, and continuous biosurveillance of NiV infection in resource-limited settings.
first_indexed 2024-03-06T05:58:17Z
format Article
id um.eprints-22882
institution Universiti Malaya
last_indexed 2024-03-06T05:58:17Z
publishDate 2017
publisher Institute of Infectious Diseases
record_format dspace
spelling um.eprints-228822019-10-26T07:50:48Z http://eprints.um.edu.my/22882/ Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli Tiong, Vunjia Lam, Chui Wan Phoon, Wai Hong AbuBakar, Sazaly Chang, Li Yen R Medicine The genes for Nipah virus (NiV) proteins were amplified from viral RNA, cloned into the plasmid pTriEx-3 Hygro, expressed, and purified using immobilized metal affinity chromatography. The recombinant N, F, and G NiV proteins (rNiV-N, rNiV-F, and rNiV-G), were successfully expressed in Escherichia coli and purified with a yield of 4, 16, and 4 mg/L, respectively. All 3 recombinant viral proteins reacted with all 19 samples of NiV-positive human sera. The rNiV-N and rNiV-G proteins were the most immunogenic. The recombinant viral proteins did not react with any of the 12 NiV-negative sera. However, serum from a patient with a late-onset relapsing NiV infection complication was found to be primarily reactive to rNiV-G only. Additionally, there is a distinctive variation in the profile of antigen-reactive bands between the sample from a case of relapsing NiV encephalitis and that of acute NiV infection. The overall findings of this study suggest that the recombinant viral proteins have the potential to be developed further for use in the detection of NiV infection, and continuous biosurveillance of NiV infection in resource-limited settings. Institute of Infectious Diseases 2017 Article PeerReviewed Tiong, Vunjia and Lam, Chui Wan and Phoon, Wai Hong and AbuBakar, Sazaly and Chang, Li Yen (2017) Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli. Japanese Journal of Infectious Diseases, 70 (1). pp. 26-31. ISSN 1344-6304, DOI https://doi.org/10.7883/yoken.JJID.2015.501 <https://doi.org/10.7883/yoken.JJID.2015.501>. https://doi.org/10.7883/yoken.JJID.2015.501 doi:10.7883/yoken.JJID.2015.501
spellingShingle R Medicine
Tiong, Vunjia
Lam, Chui Wan
Phoon, Wai Hong
AbuBakar, Sazaly
Chang, Li Yen
Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title_full Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title_fullStr Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title_full_unstemmed Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title_short Serum from Nipah virus patients recognises recombinant viral proteins produced in Escherichia coli
title_sort serum from nipah virus patients recognises recombinant viral proteins produced in escherichia coli
topic R Medicine
work_keys_str_mv AT tiongvunjia serumfromnipahviruspatientsrecognisesrecombinantviralproteinsproducedinescherichiacoli
AT lamchuiwan serumfromnipahviruspatientsrecognisesrecombinantviralproteinsproducedinescherichiacoli
AT phoonwaihong serumfromnipahviruspatientsrecognisesrecombinantviralproteinsproducedinescherichiacoli
AT abubakarsazaly serumfromnipahviruspatientsrecognisesrecombinantviralproteinsproducedinescherichiacoli
AT changliyen serumfromnipahviruspatientsrecognisesrecombinantviralproteinsproducedinescherichiacoli